Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001415889-24-022859 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Ragosa Mark | CFO | F - Tax | $26.74 | -3,216 | 23.0K | -12% | -$86.0K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Ragosa Mark | CFO | M - OptEx | — | +6,305 | 23.9K | +36% | — |
| DM | 2024-09-04 | 2024-09-01 | KNSA | Ragosa Mark | CFO | A - Grant | $0.00 | +39.5K | 33.1K | New | $0 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -6,305 | 1,861 | -77% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-09-01 | F | D | 2,260 | $26.74 | 22,053 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2024-09-01 | M | A | 4,444 | — | 24,313 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 3 | Common | Class A Ordinary Share | 2024-09-02 | F | D | 956 | $26.74 | 22,958 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2024-09-02 | M | A | 1,861 | — | 23,914 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 5 | Derivative | Restricted Share Unit | 2024-09-01 | A | A | 6,365 | $0.00 | 6,365 | D | — · — to — | 6,365 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024. |
| 6 | Derivative | Share Option | 2024-09-01 | A | A | 33,150 | $0.00 | 33,150 | D | $26.74 · — to 2034-08-31 | 33,150 Class A Ordinary Share | (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024. |
| 7 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 2,694 | $0.00 | 5,388 | D | — · — to — | 2,694 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |
| 8 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 1,750 | $0.00 | 5,250 | D | — · — to — | 1,750 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. |
| 9 | Derivative | Restricted Share Unit | 2024-09-02 | M | D | 1,861 | $0.00 | 1,861 | D | — · — to — | 1,861 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. |